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Bone mass and quality in humans are controlled by numerous genetic and environmental 
factors that are not fully understood. Increasing evidence has indicated that maternal metabolic 
dysregulation impairs multiple physiological processes in the adult offspring, but a similar effect on 
bone health is yet to be established. Here, we have analyzed the bones of first-generation offspring 
from murine dams that present metabolic syndrome due to a high-fat and high-sugar (HF/HS) diet. 
Micro-CT analyses show that the long bones of HF/HS offspring possess lower cortical bone mass 
and weaker mechanical strength than normal, even though the trabecular bone is not affected. 
Histomorphometry and serum biochemistry indicate that both bone formation and resorption are 
diminished in the HF/HS offspring. In vitro, both osteoblast and osteoclast progenitors from the HF/
HS offspring are deficient in differentiation, likely due to impairment of mitochondrial respiration. 
The study, therefore, identifies maternal metabolic health as an important environmental factor 
influencing bone volume and strength.
© Endocrine Society 2020.
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Fragility fractures caused by osteoporosis and osteopenia represent a significant health 
burden among the senior population, resulting in increased mortality and health care costs 
[1]. Current osteoporosis therapies include both antiresorptives such as bisphosphonates 
(eg, zoledronic acid) and denosumab (humanized monoclonal antibody against RANKL) and 
the bone anabolic agents teriparatide and abaloparatide targeting parathyroid hormone-
related protein receptor type 1 signaling [2]. Although the current therapies are effective in 
reducing vertebral fractures, they are less so with nonvertebral fractures, which account for 
80% of all fractures in the community [3]. For example, zoledronic acid reduced clinical ver-
tebral fracture by 77% but reduced nonvertebral fracture by 25% in postmenopausal women 
with osteoporosis [4]. Denosumab treatment for 3 years resulted in a 68% decrease in ver-
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or abaloparatide was more effective against vertebral versus nonvertebral fractures [6, 7]. 
Romosozumab, a humanized monoclonal antibody against sclerostin (an endogenous Wnt 
inhibitor) recently approved by the Food and Drug Administration, decreased vertebral 
versus nonvertebral fractures by 73% or 24%, respectively, after 12 months of use [8]. Thus, 
there remains a great unmet clinical need for therapies effectively reducing nonvertebral 
fragility fracture. Because cortical bone strength is a main determinant of nonvertebral 
fractures, it is of great clinical relevance to understand the genetic and environmental 
factors controlling cortical bone mass and quality.
Mounting evidence has implicated maternal well-being in the health of the offspring. 
Based on epidemiological evidence, David Barker first proposed adverse fetal environ-
ment as a cause for adult chronic diseases, a hypothesis commonly known as “develop-
mental origins of health and disease [9-11].” Later studies of adult children from mothers 
exposed to extreme famine during the Nazi occupation of the Netherlands revealed mul-
tiple transgenerational health consequences including increased obesity, cardiovascular 
diseases, and reduced cognitive function in late adulthood [12, 13]. Remarkably, 6 decades 
later when compared with their unexposed, sex-matched siblings, the individuals prena-
tally exposed to the famine exhibited less deoxyribonucleic acid (DNA) methylation of the 
imprinted insulin-like growth factor 2, indicating that intrauterine conditions can cause 
life-long epigenetic changes in humans [14]. A similar link between intrauterine food re-
striction and adult obesity has also been documented in rats [15]. Conversely, maternal 
obesity increased obesity in the offspring in rodents [16, 17]. In addition, maternal ex-
posure to high-fat diet leads to hyperproliferation in prostates and also increases mam-
mary cancer risk in adult offspring [18, 19]. At least a part of the adverse maternal effect 
may be explained by the inferior oocyte quality, including abnormal mitochondria associ-
ated with high-fat diet–induced obese females [20, 21]. More recently, the aberrant oocyte 
mitochondria were shown to persist for at least 3 generations in the mouse, resulting in 
transmission of metabolic dysfunction through the female germline [22]. Thus, both nu-
clear epigenetic modifications and mitochondrial changes may mediate maternal effects on 
the offspring.
Maternal diet exposure has also been implicated in offspring bone health. A  prospec-
tive study of 53922 mother-child pairs from the Danish National Birth Cohort indicates 
that consumption of Western diet (high intake of fat, meat, and potatoes and low intake of 
fruits and vegetables) in midpregnancy is associated with a significant increase in forearm 
fractures before age 16 years [23]. Similarly, in rodents, maternal high-fat diet has been 
shown to impair bone formation in both embryos and adult offspring [24-26]. The under-
lying mechanisms, however, are not fully understood.
In this study, we studied the bones of mice that were born to dams fed an HF/HS diet but 
were weaned onto regular chow diet. The HF/HS progenies exhibited a notable suppression 
in both bone formation and resorption, resulting in a net decrease in cortical bone mass and 
strength. In vitro studies showed that mitochondrial activities were compromised in the 
progenitors of either osteoblasts or osteoclasts, indicating that maternally transmitted mi-
tochondrial dysfunction may underlie the bone defect in the adult offspring.
1.  Materials and Methods
A.  Mouse Breeding and Feeding Scheme
All procedures in this study were approved by the Animal Studies Committee at Washington 
University School of Medicine and conformed to National Institutes of Health guidelines. 
The HF/HS feeding regimen for females has been previously reported [22]. Briefly, 4-week-
old C57BL6/J female mice were fed either a high-fat/ high-sugar (HF/HS) diet (test diet 
58R3; 59% fat, 26% carbohydrates [17% sucrose], 15% protein) or regular chow (chow, 
PicoLab Rodent diet 20; 13% fat, 62% carbohydrates [3.2% sucrose], 25% protein) and con-
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were fed regular chow except when they were housed with females for mating, at which time 
they shared the same diet with the females. The F1 progenies were fed regular chow after 
weaning until sacrifice. For the HF/HS-fed stud male experiment, 4-week-old C57BL6/J 
males were fed either the HF/HS diet or the regular chow for 6 weeks before they were 
switched to regular chow diet and mated with chow-fed females. Fasting glucose levels were 
measured at the end of the 6-week-long HF/HS feeding and before mating.
B.  Analyses of Bones
Femora were analyzed for bone phenotypes. The thresholds for microcomputed tomography 
(micro-CT) quantification of trabecular and cortical bone parameters were set at a lower/
upper threshold of 200/1000 and 250/1000, respectively. The cortical bone parameters were 
derived from 50 micro-CT slices (0.8 mm total) at the middle shaft of the femur; trabecular 
bone parameters were assessed in 100 micro-CT slices (1.6 mm total) immediately below 
the distal-end growth plate of the femur. For dynamic histomorphometry, calcein green 
(10 mg/kg; Sigma, Saint Louis, MO, USA) was injected intraperitoneally 7 days and 2 days 
before sacrifice. All dynamic and static histomorphometric analyses were performed on a 
minimum of 3 sections each from 3 animals per group. Quantification of calcein labeling 
was performed with the endocortical bone surface at the mid-diaphysis of the tibia on 
30μm-thick longitudinal sections (Osteo II, BIOQUANT, Nashville, TN, USA). Hematoxylin 
and eosin and tartrate-resistant acid phosphatase (TRAP) staining were performed with 
standard protocols. TRAP+ cells were counted on all trabecular bone surfaces of the distal 
femur with the BIOQUANT software (Nashville, TN, USA). Adipocytes were defined by 
their round morphology and counted within the marrow space spanning 5 mm proximally 
from the distal growth plate of the femur. The total adipocyte number was divided by 
marrow area in arbitrary unit. CTX-I and P1NP assays were performed with sera collected 
from mice after 6 hours of fasting, and with the RatLaps enzyme-linked immunosorbent 
assay kit and the Rat/Mouse P1NP enzyme immunoassay kit (both from Immunodiagnostic 
Systems, Ltd.), respectively.
C.  Cell Culture and Differentiation Assays
Bone marrow stromal cells (BMSCs) were isolated and cultured from 8-week-old F1 male 
mice as previously described [27]. BMSCs were isolated from the femur and the tibia and 
were plated in alpha minimum essential medium with 10% fetal bovine serum; medium 
was changed at day 3 and day 6. Cells were passaged once at days 7 through 8 and reseeded 
at 1x105 cells/cm2 for osteoblast differentiation in osteogenic media (alpha minimum es-
sential medium containing 10% fetal bovine serum, 1% penicillin/streptomycin, 50 µg/ml 
L-ascorbic acid, and 10 mM ß-glycerophosphate). The cells were cultured for 3 days before 
ribonucleic acid (RNA) was isolated with the QIAGEN RNeasy kit (cat# 74104).
For osteoclastogenesis, bone marrow macrophages (BMMs) were isolated from 8-week-
old F1 males and cultured in osteoclastogenic media (alpha-MEM containing 10% FBS, 1% 
penicillin/streptomycin, supernatant from the CMG 14-12 cell line, purified glutathione-S-
transferase RANKL (GST-RANKL)) based on published methods [28, 29] for 3 days before 
RNA isolation.
D.  RNA Analyses
Total RNA was isolated from tibial and femoral bone shafts (without bone marrow) of 8-week-
old F1 males. The bone shafts were pulverized at 2000 rpm for 20seconds with a Mikro-
Dismembrator in liquid nitrogen before being extracted with Trizol (Invitrogen); RNA was 
then purified with the RNeasy RNA extraction kit (Qiagen). For reverse transcription RNA 
was reverse-transcribed into complementary DNA by using iScript complementary DNA 
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Fast-start SYBR Green (Bio-Rad) in a Step-One machine (ABI). Relative expression was 
calculated with the 2–(ΔΔCt) method and normalized to ribosomal 18S RNA. qPCR primers 
are listed in Table 1.
E.  Bone Mechanical Testing
The testing was performed as a service by the Washington University Musculoskeletal 
Research Center Structure and Strength Core. Three-point bending was performed on an 
Instron Dynamight (Instron, Norwood, MA) hydraulic testing machine. Clearly dissected 
femurs were placed on a 7-mm span support such that the geometric center of the bone was 
midway between them and contacted on the posterior side. The actuator was set to displace-
ment control and moved downward toward the bone at 0.1 mm/second. Data were collected 
using a custom MATLAB 2018a (Mathworks, Natick, MA) program collecting at 100 Hz. 
Force and displacement data were analyzed in conjunction with imaging data to estimate 
material properties in addition to gross calculations.
F.  Seahorse Cellular Flux Analyses
BMSCs and BMMs were plated in XF96 plates at 100000 cells per well precoated with Cell-
Tak (BD Biosciences). On the following day, the cells were switched to XF assay medium 
modified with Dulbecco’s modified Eagle medium (Seahorse cat#102353-100) supplemented 
with 5.5 mM glucose, and further incubated in a CO2-free incubator for 1 hour. Oligomycin 
and trifluoromethoxy carbonylcynide phenylhydrazone (FCCP) (Seahorse Stress kit) were 
Table 1. Nucleotide Sequences for Quantitative Polymerase Chain Reaction Primers
Gene qPCR Sequences 5ʹ to 3ʹ
18S F: CGGCTACCACATCCAAGGAA  
R: GCTGGAATTACCGCGGCT
Runx2 F: CCAACCGAGTCATTTAAGGCT  
R: GCTCACGTCGCTCATCTTG 
Osx F: GGAAAGGAGGCACAAAGAAGC  
R: CCCCTTAGGCACTAGGAG 
Alp F: CCAACTCTTTTGTGCCAGAGA  
R: GGCTACATTGGTGTTGAGCTTTT 
Col1a1 F: TGCTTCCACGTTTACAGCTCTAAAG  
R: GTCAGGAAAGGGTCATCTGTAGTCC 
Ocn F: TGCTGGAGTGGTCTCTATGA  
R: ACCCTCTTCCCACACTGT 
Atf4 F: GCATGCTCTGTTTCGAATGGA  
R: CCAACGTGGTCAAGAGCTCAT 
Tars F: CCCTGGCCTGAATACATTAACAC  
R: CGGCTTGCTATCTTTTGCTGC 
Asns F: CAAGGAGCCCAAGTTCAGTAT  
R: GGCTGTCCTCCAGCCAAT 
NFATc1 F: GGTAACTCTGTCTTTCTAACCTTAAGCTC  
R: GTGATGACCCCAGCATGCACCAGTCACAG 
CatK F: GAAGAAGACTCACCAGAAGCAG  
R: TCCAGGTTATGGGCAGAGATT 
Cox2 F: GCCGACTAAATCAAGCAACA  
R: CAATGGGCATAAAGCTATGG 
Cox5 F: GGGTCACACGAGACAGATGA  
R: GGAACCAGATCATAGCCAACA 
ATP5γ1 F: AGTTGGTGTGGCTGGATCA  
R: GCTGCTTGAGAGATGGGTTC 
Idh3a F: CCTCCTGCTTAGTGCTGTGA  
R: CGTTGCCTCCCAGATCTTT 
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prepared in the XF assay medium with final concentration of 5 mM and 1 mM, respectively. 
At the end of the assays, cell numbers were measured for normalization.
G.  Mitochondrial DNA Measurement
Total cellular DNA was isolated from cells or tissues with DNAeasy Blood and Tissue 
Kit (Qiagen). Mitochondrial DNA content was determined by qPCR by comparing the 
mitochondrially encoded Cox2 gene to an intron of the nuclear-encoded ß-globin gene [30]. 
The following primers were used. Cox2 F: GCCGACTAAATCAAGCAACA;
Cox2 R: CAATGGGCATAAAGCTATGG. ß-globin F: GAAGCGATTCTAGGGAGCAG; 
ß-globin R: GGAGCAGCGATTCTGAGTAGA.
H.  Statistical Analyses
All quantitative data are presented as mean  ±  SD with a minimum of 3 independent 
samples. Statistical significance is determined by the Student t test or 1-way analysis of 
variance followed by the Tukey post hoc test by using the software GraphPad Prism v6.
2.  Results
A.  Diet-Induced Maternal Metabolic Syndrome Impairs Cortical Bone in the Offspring
We have previously shown that C57BL6/J females fed an HF and HS diet from 4 through 
10 weeks of age develop obesity and metabolic syndrome [22]. Importantly, offspring for at 
least 3 generations (F1-F3) from the HF/HS-fed dams develop mitochondrial dysfunction in 
skeletal muscle even when the offspring is raised on regular chow. To determine whether 
the transgenerational deleterious effect extends to bone, we have analyzed the femurs of 
the F1 offspring by micro-CT. At 4 weeks of age, the F1 females from HF/HS-fed dams 
exhibited thinner cortical bone thickness (Ct.Th) despite a normal overall size (total area 
[Tt.Ar]), resulting in a lower ratio of bone over total cross-sectional area (Ct.Ar/Tt.Ar) than 
those born to the chow-fed dams (Fig. 1A, B). Because most of the F1 females were used for 
other studies, we have mainly analyzed the F1 males for the current study [22]. Similar to 
the 4-week-old females, males born to the HF/HS-fed dams at either 8 or 26 weeks of age 
exhibited thinner cortices (cortical bone thickness) than normal (Fig. 1C-F). However, unlike 
the females, the males also showed a reduction in both total cross-sectional area (Tt.Ar) and 
the cortical bone area (Ct.Ar) while maintaining a normal ratio between the two (Fig. 1C-F). 
Three-point bending experiments showed that the femurs from 8-week-old F1 males born to 
HF/HS-fed dams displayed a smaller fracture force and yield force (Fig. 1G). Interestingly, 
the trabecular parameters were indistinguishable between the chow-fed progenies or HF/
HS-fed progenies, in either 4-week-old females or in 8- or 26-week-old males (Fig. 2A-C). 
Thus, maternal metabolic syndrome induced by HF/HS diet diminishes cortical bone ac-
crual and weakens bone strength in the progenies.
B.  Maternal Metabolic Syndrome Causes Low Turnover Osteopenia in the Offspring
To investigate the cellular basis for the cortical bone phenotype, we performed double la-
beling experiments in 8-week-old F1 males. The distance between the 2 fluorescent labels 
on the endocortical bone surfaces was notably reduced in the animals descended from HF/
HS-fed dams over the normal controls (Fig. 3A). Quantification confirmed a significant de-
crease in both mineral apposition rate and mineralizing bone surface at both periosteal and 
endosteal surfaces, resulting in a marked decrease in bone formation rate in the offspring 
of HF/HS-fed dams (Fig. 3B-D). Consistent with the double labeling results, the levels of 
aminoterminal propeptide of type I procollagen in the serum, an indicator for the overall 
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than those of chow-fed dams (Fig. 3E). Somewhat unexpectedly, the circulating levels of 
CTX-I, a cleavage product of type I collagen reflecting total bone resorption activity, was also 
reduced in the HF/HS offspring (Fig. 3F). In keeping with the decrease in bone resorption 
activity, histological staining of bone sections showed that the number of TRAP+ osteoclasts 
was diminished in the mice born to HF/HS-fed dams (Fig. 4A, B). On the other hand, his-
tology detected more adipocytes in the bone marrow of the HF/HS progenies (Fig. 4C, D). 
Thus, the bone phenotype in the offspring of HF/HS-fed dams may be characterized as low 
turnover osteopenia.
C.  Osteoblast and Osteoclast Progenitors are Impaired in HF/HS Offspring
To examine the potential maternal effect on osteoblast progenitors, we isolated BMSCs 
(known to contain osteoprogenitors) from 8-week-old F1 males born to either HF/HS-fed or 
chow-fed dams (referred to as HF/HS or chow offspring) and assessed their differentiation 
potential in vitro. After 3 days of culture in mineralization media instead of growth media, 
BMSCs from the chow offspring significantly upregulated not only the common osteoblast 
markers Runx2, Osx, Alpl. Cola1, and Ocn, but also the protein anabolism genes Atf4, Tars, 
and Asns recently shown to increase with osteoblast differentiation [31] (Fig. 5A). Although 
the same genes were also induced in BMSCs from the HF/HS offspring by the mineraliza-
tion media, their expression level was clearly diminished (Fig. 5A). In keeping with the in 
vitro results, the expression levels of the osteoblast marker genes in bone were significantly 
lower in HF/HS than chow offspring (Fig. 5B). Thus, maternal metabolic syndrome reduces 
the differentiation potential of osteoblast progenitors.
Figure 1. HF/HS-induced maternal metabolic syndrome diminishes cortical bone in F1 off-
spring. (A, C, E) Micro-CT 3-D reconstruction images of the midshaft region of the femur in 
4-week-old females (A), 8- (C) or 26-week-old males (E). (B, D, F) Quantification of cortical 
bone parameters from micro-CT scans of femurs in 4-week-old females (B), 8- (D) or 26-week-
old males (F). Ct.Ar., cortical area; Ct.Th., cortical thickness; F1, offspring; HF, high-fat; 
HS, high-sugar; micro-CT, microcomputed tomography; Tt.Ar., total area. *P < 0.05; n = 7 
or 9 for chow or HF/HS (4-week-old), respectively; n = 6 or 7 for chow or HF/HS (8-week-
old), respectively; n = 9 or 10 for chow or HF/HS (26-week-old), respectively. (G) Mechanical 
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We next investigated whether osteoclast progenitors were similarly affected. For this, 
we isolated BMMs from the F1 males and performed osteoclastogenesis assays in vitro. 
Nfatc1 and cathepsin K (CatK), representing early and late stages of osteoclast differenti-
ation respectively, were significantly induced in BMMs from the chow offspring following 
incubation in the osteoclastogenic media (Fig. 6A, B). However, the levels of either gene 
following induction of differentiation was much reduced in BMMs from HF/HS offspring. 
Thus, both osteoblast and osteoclast progenitors were negatively impacted by maternal 
metabolic syndrome.
D.  Osteoblast and Osteoclast Progenitors Exhibit Mitochondrial Dysfunction in HF/HS 
Offspring
As our previous studies have shown that maternal metabolic syndrome causes mitochon-
drial dysfunction to the offspring, we next tested whether this applied to the osteoblast or 
osteoclast progenitors. To this end, we measured the oxygen consumption rate (OCR) in 
BMSCs or BMMs isolated from 8-week-old F1 males with Seahorse technology. Both basal 
and maximal OCR in BMSCs were reduced in HF/HS offspring compared with the chow 
counterparts (Fig. 7A-C). In the BMMs of HF/HS offspring, although the basal OCR was 
relatively normal, the maximal OCR was suppressed (Fig. 7D-F). Interestingly, despite the 
decreased OCR, the genes that participate in the electron transport chain or the tricarbox-
ylic acid (TCA) cycle, such as Cox2, Cox5a, Idh3a ,or ATP5g1, were expressed at a higher 
level in the BMSCs or BMMs from HF/HS offspring than those of chow offspring (Fig. 8A, 
Figure 2. Maternal metabolic syndrome does not affect trabecular bone in F1 offspring. 
Femurs were analyzed by micro-CT in 4-week-old females (A), 8-week-old males (B), or 
26-week-old males (C). Each dot represents 1 animal. BV/TV, bone volume/tissue volume; 
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Figure 4. HF/HS offspring data exhibit decreased osteoclast number and increased bone 
marrow adipocytes. F1 males were analyzed at 8 weeks of age. Scale bar, 100 µm. (A) 
Representative images of TRAP staining on femur sections. TRAP+ osteoclasts stained 
dark red. (B) Quantification of osteoclast numbers normalized to trabecular bone sur-
face. *P < 0.05; n = 3. (C) Representative H&E staining of femur sections showing marrow 
adipocytes. (D) Quantification of bone marrow adipocytes on H&E-stained femur sections. 
*P < 0.05; n = 3. F1, offspring; H&E, hematoxylin and eosin; HF, high-fed; HS, high-sugar; 
TRAP, tartrate-resistant acid phosphatase.
Figure 3. Maternal metabolic syndrome suppresses bone formation and resorption in the off-
spring. F1 males were analyzed at 8 weeks of age. (A) Representative images for double labeling 
at the endosteal surface of the femur. (B-D) Quantification of double labeling results. MAR, min-
eral apposition rate (B); MS/BS, mineralizing surface over total bone surface (C); BFR, bone for-
mation rate (D). *P < 0.05; n = 5. (E, F) Serum levels of procollagen type I N-terminal propeptide 
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B). Moreover, the Cox2 gene in the mitochondrial genome, when normalized to the nuclear 
gene b-globin, presented a higher copy number in BMSCs or BMMs from the HF/HS offspring 
than normal (Fig. 8C, D). The increased mitochondrial number likely reflects a compensa-
tory response in the face of impaired mitochondrial function.
The results so far suggest that maternal transmission of mitochondrial dysfunction 
underlies the bone defects in the offspring. To test this notion further, we investigated 
whether males, which do not transmit their mitochondria to the next generation, could 
cause a similar bone defect in the offspring. Specifically, we raised stud males on the HF/
HS diet from 4 weeks until 10 weeks of age before mating them with chow-fed females to 
produce progenies fed with normal chow. Measurements of fasting blood glucose levels con-
firmed that the males fed with an HF/HS diet were hyperglycemic (Fig. 9A). In fact, the 
extent of hyperglycemia in the HF/HS-fed stud males was higher than that observed in 
the HS/HF-fed females, as we have previously reported [22]. However, micro-CT analyses 
Figure 5. Maternal metabolic syndrome impairs bone marrow osteoblast progenitors in 
the offspring. (A) Analyses for osteoblast differentiation in BMSCs isolated from chow or 
HF/HS offspring. mRNA levels normalized to 18S rRNA were expressed as relative values 
to those in cells from chow offspring and cultured in growth media, which was designated 
as 1. *P < 0.05, 1-way factorial ANOVA followed by Tukey post hoc test, n = 3. Alp, alakine 
phosphatase, official name Alpl; ANOVA, analysis of variance; Asns, asparagine synthetase 
Atf4, activating transcription factor 4; BMSCs, bone marrow stromal cells; Cola1, collagen 
type I alpha 1 chain; Ctrl, regular growth media; HF, high-fat; HS, high-sugar; MM, mineral-
ization media; mRNA, messenger RNA; Ocn, osteocalcin, official name Bglap; Osx, osterix, 
official name Sp7; RT-qPCR, reverse transcriptase–quantitative polymerase chain reaction; 
RNA, ribonucleic acid; rRNA, ribosomal RNA; Runx2, runt-related transcription factor 2; 
Tars, threonyl-tRNA synthetase; tRNA, transer RNA. (B) RT-qPCR analyses of osteoblast 
marker genes in the bones of chow or HF/HS 8-week-old offspring. The mRNA levels in chow 
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Figure 7. HF/HS offspring data exhibit mitochondrial dysfunction in BMSCs and BMMs. 
(A) OCR by Seahorse analyses in BMSCs. (B, C) Quantification of basal or maximal OCR in 
BMSCs. *P < 0.05; n = 3. (D) OCR by Seahorse analyses in BMMs. (E, F) Quantification of 
basal or maximal OCR in BMMs. *P < 0.05; n = 3. A/R, antimycin A/rotenone; BMMs, bone 
marrow macrophages; BMSCs, bone marrow stromal cells; HF, high-fat; HS, high-sugar; 
OCR, oxygen consumption rate; Oligo, oligomycin; FCCP: trifluoromethoxy carbonylcyanide 
phenylhydrazone.
Figure 6. Maternal metabolic syndrome impairs bone marrow osteoclast progenitors in the 
offspring. (A, B) RT-qPCR analyses for osteoclast marker genes Nfatc1 (A) and CatK (B). 
mRNA levels normalized to 18S rRNA were expressed as relative values to those in BMMs 
from chow offspring and cultured in growth media (designated 1). BMMs, bone marrow 
macrophages; CatK, cathepsin K; Ctrl, regular growth media; HF, high-fat; HS, high-sugar; 
mRNA, messenger RNA; OM, osteoclastogenic medium; RNA, ribonucleic acid; rRNA, 
ribosomal RNA; RT-qPCR, reverse transcriptase–quantitative polymerase chain reaction. 








niversity in St. Louis user on 16 N
ovem
ber 2020
doi: 10.1210/jendso/bvaa028 | Journal of the Endocrine Society | 11
detected no defects in either trabecular or cortical bone of the male or female offspring at 
either 4 or 8 weeks of age (Fig. 9B-E). Thus, the transgenerational effect of HF/HS diet on 
bone is transmitted only through females, perhaps partly via the passage of dysfunctional 
mitochondria.
3.  Discussion
We have shown that mothers with diet-induced metabolic dysregulation transmit a notable 
bone defect to their adult offspring. Specifically, both male and female offspring from the 
affected dams exhibit reduced cross-sectional size and cortical thickness in the long bones, 
resulting in a clear decrease in mechanical strength. The findings, therefore, reinforce the 
notion that intrauterine or early postnatal exposure to an adverse nutritional environment 
negatively impacts bone health in the long term.
Our findings appear to be at odds with those from a recent study [25]. There, the progenies 
born to high-fat diet–fed dams continued on an HF diet after weaning until 6 weeks of age 
before they were switched to regular chow and analyzed at 20 weeks of age. Those authors 
Figure 8. HF/HS offspring data exhibit increased mitochondria abundance in BMSCs and 
BMMs. (A, B) RT-qPCR analyses of relative mRNA levels normalized to 18S mRNA ex-
pression in BMSCs (A) or BMMs (B). Levels in cells from chow offspring were designated 
1. *P < 0.05; n = 3. ATP5g1, ATP synthase, H+ transporting, mitochondrial F0 complex, 
subunit C1 (subunit 9); BMMs, bone marrow macrophages; BMSCs, bone marrow stromal 
cells; Cox2, cytochrome c oxidase subunit 2; Cox5a, cytochrome c oxidase subunit 5a; HF, 
high-fat; HS, high-sugar; Idh3a, isocitrate dehydrogenase 3 (NAD+) alpha; mRNA, messenger 
RNA; RNA, ribonucleic acid; RT-qPCR, reverse transcriptase–quantitative polymerase chain 
reaction. (C, D) Relative abundance of mitochondrial Cox2 gene to nuclear ß-globin gene in 








niversity in St. Louis user on 16 N
ovem
ber 2020
12 | Journal of the Endocrine Society | doi: 10.1210/jendso/bvaa028
analyzed the tibia by micro-CT and reported that the male progenies had lower trabecular 
bone mass but increased cortical bone total cross-sectional area than normal. In contrast, 
we see in the femur no change in the trabecular bone but a decrease in cortical bone total 
cross-sectional area at either 8 or 24 weeks of age. Although the exact reason for the dis-
crepancy is unknown at present, it is possible that continued feeding of the HF diet to 
the progenies after weaning in the previous study might have compounded with the ma-
ternal effect to cause a different bone phenotype. Moreover, we cannot rule out that slight 
differences in diet compositions between the studies or potential differences between tibias 
and femora might account for the different outcome. Finally, as our analyses of the trabec-
ular bone were limited to micro-CT studies, detailed static and dynamic histomorphometry 
might uncover additional defects transmitted by the HF/HS-fed dams.
The bone phenotype in our study appears to be caused by defects in both bone formation 
and resorption. This notion is supported by the observation that the serum biochemical 
markers for both processes (P1NP and CTX-1, respectively) are suppressed in the affected 
offspring versus the control offspring. Whereas the cross-sectional size is determined 
mainly by outward (periosteal) de novo bone growth, commonly known as modeling, the 
Figure 9. Paternal exposure to HF/HS diet does not affect the bones of the offspring. (A) 
Blood glucose levels after overnight fasting in chow-fed or HF/HS-fed males. Four-week-old 
C57BL6/J male mice were fed chow or HS/HF diet for 6 weeks before fasting glucose levels 
were measured. (B-E) Femurs were analyzed by micro-CT in 4-week-old F1 females (B, C) or 
8-week-old F1 males (D, E) for both cortical (B, D) and trabecular (C, E) bone parameters. 
BV/TV, bone volume fraction; Ct.Ar., cortical area; Ct.Th., cortical thickness; HF, high-fat; 
HS, high-sugar; micro-CT, microcomputed tomography; Tb.N, trabecular number; Tb.Th, tra-
becular thickness; Tb.Sp, trabecular separation Tt.Ar., total area. n = 3 (A), 4 (B, C), 7 (D), or 
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cortical bone thickness depends on the opposing activities of endosteal bone formation and 
resorption, or bone remodeling. Because both cortical cross-sectional size and thickness 
are reduced in the affected offspring, the maternal factors likely affect both modeling and 
remodeling of the cortical bone. Interestingly, however, bone length, which is largely driven 
by the growth of growth plate cartilage, appears to be normal. Similarly, the trabecular bone 
is not affected, indicating that the net balance from bone remodeling remains relatively 
normal in that compartment even though both resorption and formation are compromised. 
The different outcomes between cortical and trabecular bone are not known at present, but 
they may reflect distinct remodeling dynamics between the 2 compartments.
The bone defects are likely due to a direct effect on osteoblasts and osteoclasts. In 
vitro studies showed that BMSCs or BMMs from the affected offspring were less effi-
cient in osteoblast or osteoclast differentiation, respectively. Although the precise mech-
anism for the defects in BMSCs or BMMs is not certain as present, both cell types exhibit 
deficiency in mitochondrial respiration despite increased mitochondrial DNA and gene 
expression, indicating that mitochondrial defects may be at least partially responsible. 
Since we have previously shown that the HF/HS-fed 4-week-old C57BL6/J female mice 
transmit abnormal mitochondria through oocytes to skeletal muscles of the offspring for 
multiple generations, we suspect that the mitochondrial defects observed here in BMSCs 
and BMMs are similarly inherited through the female germ line [22]. However, the ab-
normal intrauterine metabolic conditions and indirect exposure to the HF/HS diet either 
in utero or through the milk could also cause mitochondrial defects in somatic tissues in 
the offspring. Moreover, besides the mitochondrial defects, the aforementioned adverse 
conditions could lead to epigenetic changes in the nuclear genome that contribute to the 
differentiation defects of BMSC and BMMs. The HS/HF-fed stud males did not transmit 
a bone defect to the next generation, lending further support to the notion that the ma-
ternally transmitted mitochondrial defects may be responsible for the transgenerational 
bone defect. However, we could not rule out that the indirect exposure of the offspring 
to HS/HF in utero and before weaning, neither of which occurred in the HS/HF-fed stud 
male experiment, might also explain the lack of a transgenerational effect. Nonetheless, 
the current study provides evidence that the maternal metabolic state is an important 
factor influencing bone health of the next generation and potentially their predisposition 
to osteoporosis in adulthood.
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